Cedric Francois sold $399K of Apellis Pharmaceuticals (APLS)

Executed Jul 17 2025, disclosed Jul 18 2025, 1 day later.

Value, as filed

$399K

19,725 sh × $20.21

Executed

Jul 17 2025

the trade date, as filed

Disclosed

Jul 18 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CF Cedric Francois Chief Executive Officer profile →

Cedric Francois (Chief Executive Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in APLS. The largest single filing was $592K of APLS (27,192 sh × $21.77, as filed), executed Jan 22.

The name

APLS APLS APLS · 32 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Cedric Francois in APLS

APLSSALE Apellis Pharmaceuticals, Inc. $592K
27,192 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $162K
8,182 sh × $19.79
Exec Jan 20
Filed Jan 21 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $226K
10,186 sh × $22.19
Exec Jan 13
Filed Jan 15 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $6.4M
225,000 sh across 2 lots
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $2.8M
137,465 sh × $20.19
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $412K
13,551 sh × $30.43
Exec Jan 22 2025
Filed Jan 23 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $180K
6,007 sh × $29.96
Exec Jan 17 2025
Filed Jan 21 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $179K
6,247 sh × $28.70
Exec Jan 13 2025
Filed Jan 14 2025 · 5:30 PM ET